Loading data
INVXNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 978.25 m USD | 660.8 m USD | 555.54 m USD | 467.19 m USD | 287.9 m USD |
| Cost of revenue | 674.97 m USD | 428.17 m USD | 360.1 m USD | 309.07 m USD | 309.27 m USD |
| Research and development expense | 6.7 m USD | 3.7 m USD | 3 m USD | 2.5 m USD | — |
| Selling, general and administrative expense | 128.79 m USD | 116.18 m USD | 72.8 m USD | 59.19 m USD | 115.04 m USD |
| Operating profit | 132.63 m USD | 49.08 m USD | 97.28 m USD | 75.84 m USD | -125.34 m USD |
| Interest expense | 2.58 m USD | 2.43 m USD | 5.51 m USD | 4.03 m USD | 787 k USD |
| Profit before tax | 128.53 m USD | 142.81 m USD | 94.37 m USD | 72.93 m USD | -125.55 m USD |
| Income tax expense | 45.2 m USD | 2.5 m USD | 20.44 m USD | 9.7 m USD | 2.95 m USD |
| Net income (reported basis) | 83 m USD | 140 m USD | 600 k USD | 400 k USD | -128 m USD |
| Basic earnings per share | 1.21 USD/share | 2.82 USD/share | 2.39 USD/share | 2.07 USD/share | -3.63 USD/share |
| Diluted earnings per share | 1.2 USD/share | 2.77 USD/share | 2.29 USD/share | 2.01 USD/share | -3.63 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.